KymaThera develops innovative therapies focused on treating cancer, aiming to address unmet medical needs in oncology. The company leverages advanced biotechnology to create new treatment options for patients.
Founded
2024
Total Funding
Tens of millions
Total Rounds
1
First Raise
Oct 6, 2026
Latest Raise
Oct 6, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/6/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free